Podcast | The Practice of Medicine | March 8, 2021

Endocrine Disease and COVID-19

In this podcast, Dr. Veronica Piziak discusses COVID-19 and possible effects it may have on endocrine disease and explains if conditions such as thyroid cancer, Grave’s disease, and diabetes mellitus make individuals more susceptible to the virus. Dr. Piziak also provides information regarding thyroid medication and risk of viral infection.

Veronica PiziakDr. Piziak is Emeritus Director, Division of Endocrinology and Director of the Diabetes Center for Baylor Scott & White in Temple, Texas. She has attained the rank of Professor of Medicine and Endocrinology at Texas A&M University College of Medicine and is Professor of Social and Behavioral Health for Texas A&M School of Rural Public Health. 

Disclosure: Dr.Piziak does not have any relevant financial relationships or conflicts of interest.

References and Resources

  1. American Thyroid Association. Novel Coronavirus (COVID-19) and the Thyroid: Resources. https://www.thyroid.org/covid-19/.
  2. Boelaert K, Visser WE, Taylor PN, et al. Endocrinology in the time of COVID-19: Management of hyperthyroidism and hypothyroidism. Eur J Endocrinol. 2020 Jul;183(1):G33-G39.
  3. Dworakowska D, Grossman AB. Thyroid disease in the time of COVID-19. Endocrine. 2020 Jun;68(3):471-474.
  4. Lundholm MD, Poku C, Emanuele N, et al. SARS-CoV-2 (COVID-19) and the Endocrine System. J Endocr Soc. 2020 Oct 1;4(11):bvaa144.
  5. Marazuela M, Giustina A, Puig-Domingo M. Endocrine and metabolic aspects of the COVID-19 pandemic. Rev Endocr Metab Disord. 2020 Dec;21(4):495-507.
  6. Pal R, Banerjee M. COVID-19 and the endocrine system: exploring the unexplored. J Endocrinol Invest. 2020 Jul;43(7):1027-1031.